Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

A Long, Strange Trip: 510(k) Reform At One Year

02 Jan 2012

Related Content

Regulatory News In Brief

02 Jan 2012

Risk-Benefit Guidance Aims To Improve Pre-Market Review Predictability

22 Aug 2011

FDA Guidance Emphasizes Randomized, Blinded Trials For PMAs

22 Aug 2011

A “Disastrous” Draft? Device Firms Take Issue With 510(k) Modifications Guidance

05 Dec 2011

Jumpstarting U.S. Device Trials? FDA Makes Effort In New Draft Guidelines

14 Nov 2011

Challenges Remain In Linking Unique Device Identifiers To Electronic Health Records

19 Sep 2011

Additional Topics

Regulation Medical Device

More from Regulation

More from Policy & Regulation

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.